Bristol-Myers Squibb Company 13D and 13G filings for Acceleron Pharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-07-16 5:01 pm Purchase | 2020-07-01 | 13D | Acceleron Pharma Inc. XLRN | BRISTOL MYERS SQUIBB CO BMY | 7,008,510 12.000% | 7,008,510 (New Position) | Filing |